Compare Bundamedik Tbk (BMHS) vs Multi Indocitra Tbk. (MICE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bundamedik Tbk vs Multi Indocitra Tbk. — how do they compare? Bundamedik Tbk trades at Rp189 (market cap 1.62T, 35.7K 24h volume), while Multi Indocitra Tbk. trades at Rp525 (market cap 312B, 4K 24h volume). The key difference: Bundamedik Tbk is far larger — about 5.2× Multi Indocitra Tbk.'s market cap, and Bundamedik Tbk is more actively traded (35.7K versus 4K). Which is the better fit depends on your goals.
| BMHS | MICE | |
|---|---|---|
Market Cap | 1.62T | 312B |
Volume | 35.7K | 4K |
Lot | 357 | 40 |
Turnover | 6.77M | 2.1M |
Average Price | 189.63 | 525.75 |
Value | 6.77M | 2.1M |
Indicative Equilibrium Price | 190 | — |
Indicative Equilibrium Volume | 52 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bundamedik Tbk
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →About Multi Indocitra Tbk.
PT Multi Indocitra Tbk (the Company) was established under its original name of Modern Indocitra based on notarial deed No. 52 of Esther Daniar Iskandar, S.H dated January 11, 1990. The Company's articles of association has been amended several times, the latest amendment dated Aug 16, 2005, regarding the change in the Company's status from private company to public company.
Read more on MICE →
